: COVID-19: remdesivir

... > drug class > antiviral > nucleoside analogue > adenosine nucleoside analogue > remdesivir

remdesivir

Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. Remdesivir is being tested as a treatment for COVID‑19, and has been authorized for emergency use in the US, India, Singapore, and approved for use in Japan, the European Union, and Australia for people with severe symptoms. (Wikipedia)

http://data.loterre.fr/ark:/67375/C0X-JDX1LN53-7

RDF/XML TURTLE JSON-LD

Loterre